ComplementComplement assay; Complement proteins
Complement is a blood test that measures the activity of certain proteins in the liquid portion of your blood.
The complement system is a group of nearly 60 proteins that are in blood plasma or on the surface of some cells. The proteins work with your immune system and play a role to protect the body from infections, and to remove dead cells and foreign material. Rarely, people may inherit deficiency of some complement proteins. These people are prone to certain infections or autoimmune disorders.
There are nine major complement proteins. They are labeled C1 through C9. This article describes the test that measures total complement activity.
How the Test is Performed
A blood sample is needed. This is most often taken through a vein. The procedure is called a venipuncture.
How to Prepare for the Test
There is no special preparation.
How the Test will Feel
When the needle is inserted to draw blood, some people feel slight pain. Others may feel only a prick or sting. Afterward, there may be some throbbing.
Why the Test is Performed
Total complement activity (CH50, CH100) looks at the overall activity of the complement system. In most cases, other tests that are more specific for the suspected disease are done first. C3 and C4 are the complement components measured most often.
A complement test may be used to monitor people with an autoimmune disorder. It is also used to see if treatment for their condition is working. For example, people with active lupus erythematosus may have lower-than-normal levels of the complement proteins C3 and C4.
Complement activity varies throughout the body. For example, in people with rheumatoid arthritis, complement activity in the blood may be normal or higher-than-normal, but much lower-than-normal in the joint fluid.
People with some bacterial blood infections and shock often have very low C3 and components of what's known as the alternative pathway. C3 is often also low in fungal infections and some parasitic infections such as malaria.
The normal results for this test are:
- Total blood complement level: 41 to 90 hemolytic units
- C1 level: 14.9 to 22.1 mg/dL
- C3 levels: 88 to 201 mg/dL
- C4 levels: 15 to 45 mg/dL
Note: mg/dL = milligrams per deciliter.
Note: Normal value ranges may vary slightly among different laboratories. Talk to your health care provider about the meaning of your specific test results.
The examples above show the common measurements for results for these tests. Some laboratories use different measurements or may test different specimens.
What Abnormal Results Mean
Increased complement activity may be seen in:
- Certain infections
- Ulcerative colitis
Decreased complement activity may be seen in:
- Hereditary angioedema
- Kidney transplant rejection
- Lupus nephritis
- Systemic lupus erythematosus
- Rare inherited complement deficiencies
Risks associated with having blood drawn are slight, but may include:
- Excessive bleeding
- Fainting or feeling lightheaded
- Hematoma (blood accumulating under the skin)
- Infection (a slight risk any time the skin is broken)
The "complement cascade" is a series of reactions that take place in the blood. The cascade activates the complement proteins. The result is an attack unit that creates holes in the membrane of bacteria, killing them.
Chernecky CC, Berger BJ. C. In: Chernecky CC, Berger BJ, eds. Laboratory Tests and Diagnostic Procedures. 6th ed. St Louis, MO: Elsevier Saunders; 2013:266-432.
Holers VM. Complement and its receptors: new insights into human disease. Annu Rev Immunol. 2014;3:433-459. PMID: 24499275 www.ncbi.nlm.nih.gov/pubmed/24499275.
Merle NS, Church SE, Fremeaux-Bacchi V, Roumenina LT. Complement system part I - molecular mechanisms of activation and regulation. Front Immunol. 2015;6:262. PMID: 26082779 www.ncbi.nlm.nih.gov/pubmed/26082779.
Merle NS, Noe R, Halbwachs-Mecarelli L, Fremeaux-Bacchi V, Roumenina LT. Complement system part II: role in immunity. Front Immunol. 2015;6:257. PMID: 26074922 www.ncbi.nlm.nih.gov/pubmed/26074922.
Morgan BP, Harris CL. Complement, a target for therapy in inflammatory and degenerative diseases. Nat Rev Drug Discov. 2015;14(2):857-877. PMID: 26493766 www.ncbi.nlm.nih.gov/pubmed/26493766.
Review Date: 1/16/2019
Reviewed By: Gordon A. Starkebaum, MD, MACR, ABIM Board Certified in Rheumatology, Seattle, WA. Also reviewed by David Zieve, MD, MHA, Medical Director, Brenda Conaway, Editorial Director, and the A.D.A.M. Editorial team.